SUBSCRIBE
SUBSCRIBE

Brandon May

Biotech Beach
Could Fluoride be the Solution to Antibiotic Resistance? A New Study Weighs In
Scientists at the University of California (UC), Santa Barbara, believe fluoride may offer hope in the fight against antibiotic-resistant bacteria.
January 5, 2021
 · 
3 min read
 · 
Brandon May
Courtesy of Repelsteeltje/Getty Images
Policy
Pfizer, OPKO One Step Closer to Approval of Pediatric Growth Hormone Deficiency Drug Somatrogon
Pfizer and OPKO Health are one step closer to receiving approval for their jointly developed pediatric growth hormone deficiency drug, somatrogon, after the U.S. FDA recently accepted the companies’ regulatory submission for the therapy.
January 4, 2021
 · 
2 min read
 · 
Brandon May
Sarah Silbiger/Getty Images
Policy
FDA Lifts Hold on Audentes’ Trial of X-Linked Myotubular Myopathy Drug
The agency placed the hold on the Astellas company’s trial after two patients died in the trial.
December 28, 2020
 · 
2 min read
 · 
Brandon May
Job Trends
Twist Bioscience Plans to Bring 400 Jobs to Oregon with New State-of-the-Art Facility
The new state-of-the-art facility, dubbed the “Factory of the Future,” will span 110,000 square feet and will be located in the city of Wilsonville, Oregon.
December 23, 2020
 · 
3 min read
 · 
Brandon May
Photo by John Lamparski/Getty Images
BioCapital
Peter Thiel Contributes to $35 Million Financing Round for Peptilogics
A new Series B financing round sees Peter Thiel, co-founder of PayPal and Palantir Technologies, joining entrepreneur Christian Angermayer in investing $35 million in Pittsburgh, Penn.-based biotech Peptilogics.
December 22, 2020
 · 
2 min read
 · 
Brandon May
Setmelanotide can be expected in the market soon b
Drug Development
Rhythm Pharmaceuticals’ Anti-Obesity Drug Setmelanotide Shows Promising Findings in Phase III Trial
Rhythm Pharmaceuticals announced on Tuesday that its hunger and severe obesity drug, setmelanotide, significantly reduced weight and hunger scores in people with Bardet-Biedl syndrome and Alström syndrome.
December 22, 2020
 · 
3 min read
 · 
Brandon May
Drug Development
Experts Hopeful COVID-19 Vaccines Will Be Effective Against More Infectious, Rapidly Spreading Strain
A new and more easily transmissible strain of COVID-19, dubbed VUI-202012/01, has now been reported in at least six different countries and global territories since it first appeared in the U.K. a few weeks ago.
December 21, 2020
 · 
3 min read
 · 
Brandon May
Drug Development
Daiichi Sankyo’s Mirogabalin Displays Significant Reduction in Post-SCI Neuropathic Pain
A phase 3 study from Daiichi Sankyo Company conducted in Japan, South Korea and Taiwan found that mirogabalin, an orally administered gabapentinoid, was associated with a significantly greater improvement in pain among patients with central neuropathic pain after spinal cord injury compared with placebo.
December 18, 2020
 · 
3 min read
 · 
Brandon May
BioForest
Brain Fog Explained as Study Shows SARS-CoV-2 Crosses Blood-Brain Barrier
A study in Nature Neuroscience shows SARS-CoV-2, the virus responsible for COVID-19, is capable of crossing the blood-brain barrier, likely contributing to symptoms of brain fog and other cognitive effects reported by people infected with the virus.
December 18, 2020
 · 
2 min read
 · 
Brandon May
Business
Surface Oncology, GSK Enter $815 Million Agreement to Advance Immunotherapy Agent
Surface Oncology has agreed to grant exclusive worldwide licensing rights to GlaxoSmithKline for the development and commercialization of Surface Oncology’s SRF813, a fully human IgG1 antibody and immunotherapy designed to treat cancer.
December 17, 2020
 · 
3 min read
 · 
Brandon May
FDA
FDA Approves First Non-Prescription, OTC Test for At-Home COVID-19 Detection
The U.S. Food and Drug Administration has authorized the first non-prescription, over-the-counter, at-home antigen test that can be used to identify infection with SARS-CoV-2, the virus responsible for COVID-19, in people two years of age or older.
December 16, 2020
 · 
3 min read
 · 
Brandon May
Drug Development
Experts Say Benefits of COVID-19 Vaccines Outweigh Risks of Reported Temporary Side Effects
After four people in the Pfizer-BioNTech’s and three people in Moderna’s COVID-19 vaccine trials developed temporary facial weakness or paralysis, some people became concerned that it could happen to them. But experts suggest that the condition, known as Bell’s palsy, is fairly prevalent in the population and generally transient.
December 16, 2020
 · 
3 min read
 · 
Brandon May
Business
Allogene, Overland Form Joint Venture to Advance Allogenic CAR T Cell Therapies in China
Clinical-stage biotechnology company Allogene Therapeutics and start-up company Overland Pharmaceuticals are forming a new joint company named Allogene Overland Biopharm.
December 15, 2020
 · 
2 min read
 · 
Brandon May
Korsuva is a late stage kidney disease treatment.
Bio NC
Anteris Invests in Nrf2 Activator to Combat Renal Disease
vTv Therapeutics has provided worldwide rights for its novel clinical-stage Nrf2 activator compound, HPP971, to newly formed Anteris Bio.
December 15, 2020
 · 
2 min read
 · 
Brandon May
Business
Long-Tenured MassBio CEO Robert Coughlin Steps Down, Extols Industry’s Accelerated Growth
Robert Coughlin announced in an open letter on Monday that he is leaving the Massachusetts Biotechnology Council (MassBio) following a 13-year tenure as the organization’s president and CEO.
December 14, 2020
 · 
2 min read
 · 
Brandon May
Load More